A citation-based method for searching scientific literature

Eun Young Kang, Nicholas Jp Wiebe, Christa Aubrey, Cheng-Han Lee, Michael S Anglesio, Derek Tilley, Prafull Ghatage, Gregg S Nelson, Sandra Lee, Martin Köbel. J Pathol Clin Res 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
Julie M Cunningham, Stacey J Winham, Chen Wang, Britta Weiglt, Zhuxuan Fu, Sebastian M Armasu, Bryan M McCauley, Alison H Brand, Yoke-Eng Chiew, Esther Elishaev,[...]. Cancer Epidemiol Biomarkers Prev 2022
1
100

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.
Martin Köbel, Steve E Kalloger, Patricia M Baker, Carol A Ewanowich, Jocelyne Arseneau, Viktor Zherebitskiy, Soran Abdulkarim, Samuel Leung, Máire A Duggan, Dan Fontaine,[...]. Am J Surg Pathol 2010
100
100

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Aline Talhouk, Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S Chiu, Stefan Kommoss, Huei San Leong, Stephanie Chen, Maria P Intermaggio,[...]. Clin Cancer Res 2020
19
100

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Martin Köbel, Steve E Kalloger, Jon Carrick, David Huntsman, Haider Asad, Esther Oliva, Carol A Ewanowich, Robert A Soslow, C Blake Gilks. Am J Surg Pathol 2009
149
100

Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Raunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, Stanislav Volik, Yen-Yi Lin, Shawn Anderson, Hannah Kim, Anne M Haegert, Shane Colborne,[...]. Cancer Res 2021
5
100

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.
David S P Tan, Marjan Iravani, W Glenn McCluggage, Maryou B K Lambros, Fernanda Milanezi, Alan Mackay, Charles Gourley, Felipe C Geyer, Radost Vatcheva, Joanne Millar,[...]. Clin Cancer Res 2011
91
100

SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
Basile Tessier-Cloutier, Mackenzie Coatham, Mark Carey, Gregg S Nelson, Sarah Hamilton, Amy Lum, Robert A Soslow, Colin Jr Stewart, Lynne M Postovit, Martin Köbel,[...]. J Pathol Clin Res 2021
15
100

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
463
100

Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma.
Dylan Z Dieters-Castator, Peter F Rambau, Linda E Kelemen, Gabrielle M Siegers, Gilles A Lajoie, Lynne-Marie Postovit, Martin Köbel. Clin Cancer Res 2019
18
100

Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary: Incidence and Morphologic Associations in 109 Cases.
Jennifer A Bennett, Vicente Morales-Oyarvide, Sharon Campbell, Teri A Longacre, Esther Oliva. Am J Surg Pathol 2016
34
100

Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma.
Katharina Wiedemeyer, Linyuan Wang, Eun Young Kang, Shuhong Liu, Young Ou, Linda E Kelemen, Lukas Feil, Michael S Anglesio, Sarah Glaze, Prafull Ghatage,[...]. Int J Gynecol Pathol 2022
2
100

Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma.
Saira Khalique, Sarah Nash, David Mansfield, Julian Wampfler, Ayoma Attygale, Katherine Vroobel, Harriet Kemp, Richard Buus, Hannah Cottom, Ioannis Roxanis,[...]. Cancers (Basel) 2021
3
100

Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Martin Köbel, Steve E Kalloger, David G Huntsman, Jennifer L Santos, Kenneth D Swenerton, Jeffrey D Seidman, C Blake Gilks. Int J Gynecol Pathol 2010
240
100

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
Peter F Rambau, Robert A Vierkant, Maria P Intermaggio, Linda E Kelemen, Marc T Goodman, Esther Herpel, Paul D Pharoah, Stefan Kommoss, Mercedes Jimenez-Linan, Beth Y Karlan,[...]. J Pathol Clin Res 2018
37
100

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
J M Piek, P J van Diest, R P Zweemer, J W Jansen, R J Poort-Keesom, F H Menko, J J Gille, A P Jongsma, G Pals, P Kenemans,[...]. J Pathol 2001
489
100

Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?
Dawn R Cochrane, Basile Tessier-Cloutier, Katherine M Lawrence, Tayyebeh Nazeran, Anthony N Karnezis, Clara Salamanca, Angela S Cheng, Jessica N McAlpine, Lien N Hoang, C Blake Gilks,[...]. J Pathol 2017
44
100

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Robert A Soslow, Guangming Han, Kay J Park, Karuna Garg, Narciso Olvera, David R Spriggs, Noah D Kauff, Douglas A Levine. Mod Pathol 2012
133
100

Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.
Marta Llaurado Fernandez, Amy Dawson, Hannah Kim, Nicole Lam, Holly Russell, Maegan Bruce, Madison Bittner, Joshua Hoenisch, Stephanie A Scott, Aline Talhouk,[...]. Gynecol Oncol 2020
8
100


Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Ryusuke Murakami, Noriomi Matsumura, Masaki Mandai, Kosuke Yoshihara, Hiroshi Tanabe, Hidekatsu Nakai, Koji Yamanoi, Kaoru Abiko, Yumiko Yoshioka, Junzo Hamanishi,[...]. Am J Pathol 2016
45
100

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
586
100

A Comprehensive Review of Ovarian Serous Carcinoma.
Yuichiro Hatano, Kayoko Hatano, Maho Tamada, Ken-Ichirou Morishige, Hiroyuki Tomita, Hiroyuki Yanai, Akira Hara. Adv Anat Pathol 2019
21
100

Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.
Martin Köbel, Li Luo, Xin Grevers, Sandra Lee, Angela Brooks-Wilson, C Blake Gilks, Nhu D Le, Linda S Cook. Int J Gynecol Pathol 2019
25
100

Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Monica Rodriguez, Eun Young Kang, Kyo Farrington, Linda S Cook, Nhu D Le, Anthony N Karnezis, Cheng-Han Lee, Gregg S Nelson, Tatjana Terzic, Sandra Lee,[...]. Am J Surg Pathol 2021
2
100

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput,[...]. PLoS Med 2008
577
100

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
396
100

Copy number signatures and mutational processes in ovarian carcinoma.
Geoff Macintyre, Teodora E Goranova, Dilrini De Silva, Darren Ennis, Anna M Piskorz, Matthew Eldridge, Daoud Sie, Liz-Anne Lewsley, Aishah Hanif, Cheryl Wilson,[...]. Nat Genet 2018
153
100


Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.
Martin Köbel, Anna M Piskorz, Sandra Lee, Shuhong Lui, Cecile LePage, Francesco Marass, Nitzan Rosenfeld, Anne-Marie Mes Masson, James D Brenton. J Pathol Clin Res 2016
188
100

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Lauren C Peres, Kara L Cushing-Haugen, Martin Köbel, Holly R Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M Schildkraut, Jennifer A Doherty. J Natl Cancer Inst 2019
164
100

Spectrum of BRAF Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.
M Herman Chui, Jason C Chang, Yanming Zhang, Ahmet Zehir, Alison M Schram, Jason Konner, Alexander E Drilon, Arnaud Da Cruz Paula, Britta Weigelt, Rachel N Grisham. JCO Precis Oncol 2021
2
100

Therapeutic options for mucinous ovarian carcinoma.
Kylie L Gorringe, Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, David D L Bowtell, Michael Christie,[...]. Gynecol Oncol 2020
18
100

Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
Mackenzie Coatham, Xiaodong Li, Anthony N Karnezis, Lien N Hoang, Basile Tessier-Cloutier, Bo Meng, Robert A Soslow, C Blake Gilks, David G Huntsman, Colin J R Stewart,[...]. Mod Pathol 2016
60
100

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.
Alon D Altman, Gregg S Nelson, Prafull Ghatage, John B McIntyre, David Capper, Pamela Chu, Jill G Nation, Anthony N Karnezis, Guangming Han, Steve E Kalloger,[...]. Mod Pathol 2013
36
100

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.
Roel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, Diana Hubbard, Hailei Zhang, Chad J Creighton, Sian Fereday, Michael Lawrence, Scott L Carter, Craig H Mermel,[...]. J Clin Invest 2013
378
100

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.
Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai, Lu-Te Chang. J Ovarian Res 2020
4
100

Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Peter F Rambau, John B McIntyre, Jennifer Taylor, Sandra Lee, Travis Ogilvie, Anna Sienko, Don Morris, Máire A Duggan, W Glenn McCluggage, Martin Köbel. Am J Surg Pathol 2017
34
100

The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas.
Lise M van Wijk, Sylvia Vermeulen, Matty Meijers, Manuela F van Diest, Natalja T Ter Haar, Marthe M de Jonge, Nienke Solleveld-Westerink, Tom van Wezel, Dik C van Gent, Judith R Kroep,[...]. Cancers (Basel) 2020
16
100

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, Pauline Krämer, Evan S Cairns, Derek S Chiu, Samuel Cy Leung, Eun Young Kang, Nicola S Meagher, Catherine J Kennedy,[...]. J Pathol 2022
2
100


Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Weiva Sieh, Martin Köbel, Teri A Longacre, David D Bowtell, Anna deFazio, Marc T Goodman, Estrid Høgdall, Suha Deen, Nicolas Wentzensen, Kirsten B Moysich,[...]. Lancet Oncol 2013
255
100

Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
Dane Cheasley, Abhimanyu Nigam, Magnus Zethoven, Sally Hunter, Dariush Etemadmoghadam, Timothy Semple, Prue Allan, Mark S Carey, Marta L Fernandez, Amy Dawson,[...]. J Pathol 2021
18
100

Cancer-Associated Mutations in Endometriosis without Cancer.
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, Tayyebeh M Nazeran, Michaël Noë, Hugo M Horlings, Amy Lum, Siân Jones, Janine Senz, Tamer Seckin,[...]. N Engl J Med 2017
289
100

Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes.
Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, Laurie Elit, Melica Nourmoussavi, Sarah Glaze, Lesley Roberts, Saul L Offman, Kurosh Rahimi, Alice Lytwyn,[...]. Gynecol Oncol 2020
4
100

High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
Hisham Assem, Peter F Rambau, Sandra Lee, Travis Ogilvie, Anna Sienko, Linda E Kelemen, Martin Köbel. Am J Surg Pathol 2018
22
100

Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype.
Masataka Takenaka, Martin Köbel, Dale W Garsed, Sian Fereday, Ahwan Pandey, Dariush Etemadmoghadam, Joy Hendley, Ayako Kawabata, Daito Noguchi, Nozomu Yanaihara,[...]. Clin Cancer Res 2019
15
100

Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary.
Rachel Sue-A-Quan, Palak G Patel, Noor Shakfa, May-Phyo Nyi Nyi, Afrakoma Afriyie-Asante, Eun Young Kang, Martin Köbel, Madhuri Koti. Gynecol Oncol 2021
3
100

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
Dariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, Craig Mermel, Joshy George, Gad Getz, Richard Tothill, Aikou Okamoto, Maria B Raeder, Paul Harnett,[...]. Clin Cancer Res 2009
198
100

ARID1A mutations in endometriosis-associated ovarian carcinomas.
Kimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, Yongjun Zhao, Kane Tse, Thomas Zeng, Janine Senz, Melissa K McConechy, Michael S Anglesio, Steve E Kalloger,[...]. N Engl J Med 2010
100

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Ellen L Goode, Matthew S Block, Kimberly R Kalli, Robert A Vierkant, Wenqian Chen, Zachary C Fogarty, Aleksandra Gentry-Maharaj, Aleksandra Tołoczko, Alexander Hein, Aliecia L Bouligny,[...]. JAMA Oncol 2017
166
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.